Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas

被引:62
作者
Ueda, M
Terai, Y
Yamashita, Y
Kumagai, K
Ueki, K
Yamaguchi, H
Akise, D
Hung, YC
Ueki, M
机构
[1] Osaka Med Coll, Dept Obstet & Gynecol, Osaka 5698686, Japan
[2] China Med Coll, Dept Obstet & Gynecol, Taichung, Taiwan
关键词
VEGF-C; MMP; invasion; angiogenesis; cervical carcinoma;
D O I
10.1002/ijc.10193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The correlation between vascular endothelial growth factor (VEGF)-C gene expression and in vitro invasive activity and matrix metalloproteinase (MMP)-2 or 9 gene expression and proteolytic activity in 11 cervical carcinoma cell lines, was investigated. Immunohistochemical expression of VEGF-C in 52 cervical carcinoma tissues was also correlated with tumor aggressiveness with respect to clinicopathologic features, tumor vascularity, MMP-2 expression and patient outcome. Expression of VEGF-C mRNA differed remarkably among the cell lines and there was a statistical correlation between VEGF-C gene expression and the number of invaded tumor cells (p = 0.0009) and MMP-2 gene expression and activity (p < 0.05). Anti-VEGF-C antibody inhibited the invasive and proteolytic activity of tumor cells in a concentration-dependent manner. VEGF-C or MMP-2 expression in clinical tissue samples was well correlated with depth of myometrial invasion, endometrial invasion, pelvic lymphnode metastasis and tumor vascularity (p < 0.05) and there was a close relation between VEGF-C and MMP-2 expression (p < 0.0001) in cervical carcinomas. Overall survival rates for 14 patients with strong VEGF-C staining tumors were lower than those for 38 patients with weak VEGF-C staining tumors (P = 0.0132) and VEGF-C tissue status emerged as an independent prognostic parameter (p = 0.0232). These results suggest that VEGF-C expression is closely related to invasion phenotype and affects the patient's survival in cervical carcinomas. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 49 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] ALBINI A, 1987, CANCER RES, V47, P3239
  • [3] [Anonymous], ACTA OBST GYNAEC JPN
  • [4] Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
    Bunone, G
    Vigneri, P
    Mariani, L
    Butó, S
    Collini, P
    Pilotti, S
    Pierotti, MA
    Bongarzone, I
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) : 1967 - 1976
  • [5] VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION
    CONNOLLY, DT
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) : 219 - 223
  • [6] THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS
    FIDLER, IJ
    ELLIS, LM
    [J]. CELL, 1994, 79 (02) : 185 - 188
  • [7] Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis
    Folkman, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) : 1757 - 1763
  • [8] ANGIOGENIC FACTOR
    FURUKAWA, T
    YOSHIMURA, A
    SUMIZAWA, T
    HARAGUCHI, M
    AKIYAMA, S
    FUKUI, K
    ISHIZAWA, M
    YAMADA, Y
    [J]. NATURE, 1992, 356 (6371) : 668 - 668
  • [9] ANGIOGENIC ACTIVITY OF ENZYMES
    HARAGUCHI, M
    MIYADERA, K
    UEMURA, K
    SUMIZAWA, T
    FURUKAWA, T
    YAMADA, K
    AKIYAMA, S
    YAMADA, Y
    [J]. NATURE, 1994, 368 (6468) : 198 - 198
  • [10] ELECTROPHORETIC ANALYSIS OF PLASMINOGEN ACTIVATORS IN POLYACRYLAMIDE GELS CONTAINING SODIUM DODECYL-SULFATE AND COPOLYMERIZED SUBSTRATES
    HEUSSEN, C
    DOWDLE, EB
    [J]. ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) : 196 - 202